Application | Comment | Organism |
---|---|---|
medicine | development of antiviral agents against poxviruses | Vaccinia virus |
Cloned (Comment) | Organism |
---|---|
cloned into the pDuetMxe vector for overexpression in Escherichia coli BL21DE3pLysS cells | Vaccinia virus |
Protein Variants | Comment | Organism |
---|---|---|
D151A | mutant with amino acid active site substitution | Vaccinia virus |
D151N | mutant with amino acid active site substitution | Vaccinia virus |
D152A | mutant with amino acid active site substitution | Vaccinia virus |
D152N | mutant with amino acid active site substitution | Vaccinia virus |
D155A | mutant with amino acid active site substitution | Vaccinia virus |
D30A | mutant with amino acid active site substitution | Vaccinia virus |
D30N | mutant with amino acid active site substitution | Vaccinia virus |
E81A | mutant with amino acid active site substitution | Vaccinia virus |
E81Q | mutant with amino acid active site substitution | Vaccinia virus |
K124A | mutant with amino acid active site substitution | Vaccinia virus |
R121A | mutant with amino acid active site substitution | Vaccinia virus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Vaccinia virus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
purified by dual affinity chromatography | Vaccinia virus |
Synonyms | Comment | Organism |
---|---|---|
A22 resolvase | - |
Vaccinia virus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
resolvase cleavage assay | Vaccinia virus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | - |
resolvase cleavage assay | Vaccinia virus |